SCHEDULE 13D/A: Former Pluri Inc. Executive Amends Ownership Filing, Discloses Recent Share Sales
Beneficial Ownership Amendment
Chen Franco-Yehuda, a former executive officer of Pluri Inc., filed an amended Schedule 13D, detailing her beneficial ownership of 0.51% of common shares and recent open market sales.
Summary
- Chen Franco-Yehuda, a former executive officer of Pluri Inc., filed an Amendment No. 1 to her Schedule 13D.
- She beneficially owns 40,064 Common Shares of Pluri Inc., representing approximately 0.51% of the outstanding shares.
- These shares were acquired for investment purposes and as compensation for her prior service as an executive officer of Pluri Inc.
- Her holdings include shares held directly and those issuable upon the exercise of options and vesting of RSUs.
- The Reporting Person's current principal occupation is Chief Financial Officer of DarioHealth Corp.
- She reported selling a total of 11,782 shares on April 24, 2025, through open market transactions at prices ranging from $5.23 to $6.80 per share.
- The Reporting Person states no current plans for extraordinary corporate transactions, management changes, or changes to the Issuer's capitalization or dividend policy, but reserves the right to review her position and formulate plans in the future.
Sentiment
Score: 5
Explanation: Neutral. This is a factual disclosure of beneficial ownership and share sales by a former executive, with no explicit positive or negative implications for the company's operations or future prospects. The sales are a fact of the individual's portfolio management.
Future Outlook
The Reporting Person stated that she has no current plans or proposals for extraordinary corporate transactions, changes in management, capitalization, or dividend policy of Pluri Inc. However, she reserves the right to review her position and formulate new plans or proposals regarding her holdings at any time.
Industry Context
This filing is a standard regulatory disclosure of beneficial ownership and changes in holdings by an individual, not directly related to broader industry trends. It provides transparency regarding a former executive's stake in Pluri Inc. and her recent trading activity.
Stakeholder Impact
- Shareholders: Provides transparency regarding a former executive's ownership stake and recent trading activity, which could influence investor perception of insider confidence.
Next Steps
- The Reporting Person may, at any time and from time to time, review or reconsider her position and formulate plans or proposals with respect to her holdings in Pluri Inc.
Key Dates
| Date | Description |
|---|---|
| 04/27/2023 | Date of event which required the initial Schedule 13D filing. |
| 04/24/2025 | Date of reported open market share sales by Chen Franco-Yehuda. |
| 06/04/2025 | Date as of which Pluri Inc. reported 7,875,555 common shares outstanding. |
| 06/09/2025 | Date of signature for Amendment No. 1 to Schedule 13D. |
Keywords
Pluri Inc., Schedule 13D, Beneficial Ownership, Common Shares, Chen Franco-Yehuda, SEC Filing, Share Sales, Executive Compensation, DarioHealth Corp.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.